Novo Uses UK Academia To Feed Diabetes Pipeline Despite Brexit Doubts
Executive Summary
Novo Nordisk, which says it still has faith in the UK's life science expertise even in the face of Brexit disruption, plans to establish a new research center at the University of Oxford – but will this be enough to help plump up its lackluster pipeline?
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.